Mosquitoes engineered to swap out an amino acid in a key protein were resistant to malaria infection, preventing them from transmitting the disease.

“Man on Fire” Syndrome, Ion Channels, and the Quest for Safer Pain Treatments Neuroscientist and clinician Stephen Waxman explores new strategies to break the circuit of neuropathic pain.

Tick Troubles: Lyme Disease Persistence, Red Meat Allergy Spread, and Vaccine Development Ticks spread pathogenic infections, and surprisingly, immune reactions. New vaccine candidates may help reduce ...

Anticipation of Infection, Even in Virtual Reality, Triggers Immune Responses A virtual reality study showed that the brain can detect potential infectious threats and prime the immune system, ...

Prenatal Exposure to Cannabis Affects the Developing Brain Children born to moms who smoked or ingested marijuana during pregnancy suffer higher rates of depression, hyperactivity, and inattention.

AI-based simulation models are poised to help cell biologists cut costs, ask smarter questions, and do more with less.

Leica Biosystems, a global leader in anatomic and digital pathology solutions, today unveiled ChromoPlex III Triple Detection RUO, a chromogenic multiplex immunohistochemistry detection system ...

The drug discovery field is undergoing a rapid transformation, driven by advances in artificial intelligence (AI) and single-cell genomics. Traditional models often lack the resolution to uncover ...

Unraveling Complex Biology with Five-Dimensional Multiomics Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.

Chromosomes in Focus: Origins, Genes, and Cancer In the 150 years since chromosomes were first discovered, scientists have studied them in various contexts, from insect cells to artificial systems.

Australian researchers are using peptides isolated from spider venom to develop treatments for a range of neurological and cardiovascular disorders.

A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with fewer off-target effects.